FIXX - Homology Medicines GAAP EPS of -$0.50 beats by $0.04 revenue of $0.8M misses by $0.21M
2023-05-11 17:20:20 ET
- Homology Medicines press release ( NASDAQ: FIXX ): Q1 GAAP EPS of -$0.50 beats by $0.04 .
- Revenue of $0.8M (flat Y/Y) misses by $0.21M .
- As of March 31, 2023, Homology had approximately $150.0 million in cash, cash equivalents and short-term investments. Based on current projections, Homology expects cash resources to fund operations into the fourth quarter of 2024.
For further details see:
Homology Medicines GAAP EPS of -$0.50 beats by $0.04, revenue of $0.8M misses by $0.21M